Sign in

Publication

Bevacizumab specifically decreases elevated levels of circulating KIT+CD11b+ cells and IL-10 in metastatic breast cancer patients

Journal Paper/Review - Mar 8, 2016

Cattin Sarah, Fellay Benoît, Pradervand Sylvain, Trojan Andreas, Ruhstaller Thomas, Rüegg Curzio, Fürstenberger Gregor

Cattin, Sarah
1
0
Fellay, Benoît
1
0
Pradervand, Sylvain
1
0
Trojan, Andreas
4
0
Ruhstaller, Thomas
83
24
Rüegg, Curzio
2
0
Fürstenberger, Gregor
1
0

We use cookies and tracking technologies according to our privacy policy to provide you with the best possible web experience. To the privacy policy